AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35286750 — intervention group
Group type: COMPARATOR
Intervention: Control group (C-G, 22 patients)
Number of subjects: 44
Study 32602233 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended dairy (RDa; n = 24)
Number of subjects: 54
Study 32602233 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dairy (LDa; n = 22)
Number of subjects: 54
Study 32602233 — intervention group
Group type: COMPARATOR
Intervention: Control (Con; n = 8)
Number of subjects: 54
Study 36189778 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral strategies (e.g., prompting and rewards)
Number of subjects: 193
Study 36189778 — intervention group
Group type: EXPERIMENTAL
Intervention: Unintended negative effects assessment
Number of subjects: 193
Study 33485454 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 60
Study 33485454 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD)
Number of subjects: 60
Study 33485454 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 60
Study 33485454 — intervention group
Group type: COMPARATOR
Intervention: BPD and RYGB (compared to medical therapy)
Number of subjects: 60
Study 33485454 — intervention group
Group type: EXPERIMENTAL
Intervention: BPD
Number of subjects: 60
Study 33485454 — intervention group
Group type: EXPERIMENTAL
Intervention: RYGB
Number of subjects: 60
Study 32195954 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin therapy (20 minutes)
Number of subjects: 20
Study 32195954 — intervention group
Group type: COMPARATOR
Intervention: Control (no paraffin therapy)
Number of subjects: 20
Study 36126995 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual CF care plus a longitudinal palliative care intervention delivered by a palliative care specialist
Number of subjects: 264
Study 36126995 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual CF care plus a longitudinal palliative care intervention
Number of subjects: 264
Study 33319250 — intervention group
Group type: COMPARATOR
Intervention: ART children
Number of subjects: 57
Study 33319250 — intervention group
Group type: COMPARATOR
Intervention: Culture media
Number of subjects: 57
Study 33992897 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled intravenous analgesia (PCA)
Number of subjects: 43
Study 33992897 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EDA)
Number of subjects: 43
Study 33992897 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 43
Study 33992897 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 43
Study 32081656 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeping on an inflatable cushion elevating the upper body by 30º
Number of subjects: 134
Study 32081656 — intervention group
Group type: COMPARATOR
Intervention: Sham pillow in a horizontal position (Control)
Number of subjects: 134
Study 33477106 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive cooldown
Number of subjects: 16
Study 33477106 — intervention group
Group type: COMPARATOR
Intervention: Active cooldown
Number of subjects: 16
Study 33477106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooldown duration of 15 minutes
Number of subjects: 16
Study 33477106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooldown duration of 10 minutes
Number of subjects: 16
Study 33477106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooldown duration of 5 minutes
Number of subjects: 16
Study 35147680 — intervention group
Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (40mg/kg intravenous liposomal amphotericin B administered in 8 equal doses over 24 days)
Number of subjects: 150
Study 35147680 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (30mg/kg intravenous liposomal amphotericin B administered in 6 equal doses over 24 days + 1.4g oral miltefosine administered in two daily doses of 50mg over 14 days)
Number of subjects: 150
Study 35147680 — intervention group
Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (excluding those with concurrent tuberculosis)
Number of subjects: 150
Study 35147680 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (excluding those with concurrent tuberculosis)
Number of subjects: 150
Study 33382101 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) as an adjunct to scaling and root planing (ScRp)
Number of subjects: 12
Study 33382101 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (ScRp) only
Number of subjects: 12
Study 33382101 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 12
Study 32796259 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise (n=86)
Number of subjects: 264
Study 32796259 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth exercise (n=95)
Number of subjects: 264
Study 32796259 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=83)
Number of subjects: 264
Study 35986498 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAVY‐IT
Number of subjects: 27
Study 35986498 — intervention group
Group type: EXPERIMENTAL
Intervention: MODERATE‐IT
Number of subjects: 27
Study 35986498 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (both MODERATE‐IT and HEAVY‐IT)
Number of subjects: 27
Study 33119948 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 g day‐1 RS‐enriched potatoes (approximately two potatoes; 18 g RS)
Number of subjects: 19
Study 33119948 — intervention group
Group type: COMPARATOR
Intervention: CHO‐based control foods
Number of subjects: 19
Study 33026166 — intervention group
Group type: EXPERIMENTAL
Intervention: BACPPI (20 mg of rabeprazole, 1000 mg of amoxicillin, 500 mg of clarithromycin, and 220 mg of bismuth potassium citrate) for 10 days
Number of subjects: 240
Study 33026166 — intervention group
Group type: EXPERIMENTAL
Intervention: BACPPI (20 mg of rabeprazole, 1000 mg of amoxicillin, 500 mg of clarithromycin, and 220 mg of bismuth potassium citrate) for 14 days
Number of subjects: 240
Study 33026166 — intervention group
Group type: COMPARATOR
Intervention: BACPPI-10 group
Number of subjects: 240
Study 33026166 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study 36016905 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanistic nursing practice guidelines for stroke patients
Number of subjects: 25
Study 32152175 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma adsorption
Number of subjects: 0
Study 32152175 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34881843 — intervention group
Group type: EXPERIMENTAL
Intervention: CGF+CAF
Number of subjects: 18
Study 34881843 — intervention group
Group type: COMPARATOR
Intervention: PRF+CAF
Number of subjects: 18
Study 32304333 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial richness and specific phylogenetic classes
Number of subjects: 357
Study 32304333 — intervention group
Group type: EXPERIMENTAL
Intervention: Abundance of genera in Gammaproteobacteria (Haemophilus, Klebsiella, Buttiauxella, Raoultella)
Number of subjects: 357
Study 32304333 — intervention group
Group type: EXPERIMENTAL
Intervention: Building age
Number of subjects: 357
Study 32304333 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight of vacuum dust
Number of subjects: 357
Study 33503390 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeogo™ exoskeleton
Number of subjects: 29
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased education
Number of subjects: 26431
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure
Number of subjects: 26431
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol
Number of subjects: 26431
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL cholesterol
Number of subjects: 26431
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking initiation
Number of subjects: 26431
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 26431
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 26431
Study 32996171 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure and pulse pressure
Number of subjects: 26431
Study 32639057 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal Jelly 100 mg kg‐1 BW‐1 (RJ100)
Number of subjects: 25
Study 32639057 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal Jelly 200 mg kg‐1 BW‐1 (RJ200)
Number of subjects: 25
Study 32639057 — intervention group
Group type: COMPARATOR
Intervention: Control group (RJ0)
Number of subjects: 25
Study 34029321 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ soccer specific warm-up programme
Number of subjects: 626
Study 34029321 — intervention group
Group type: COMPARATOR
Intervention: Usual warm up exercises
Number of subjects: 626
Study 32658394 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior Release (PR)
Number of subjects: 125
Study 32658394 — intervention group
Group type: EXPERIMENTAL
Intervention: Posteromedial Release (PMR)
Number of subjects: 125
Study 32658394 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative correction
Number of subjects: 125
Study 36273521 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine initial consultation
Number of subjects: 476
Study 36273521 — intervention group
Group type: COMPARATOR
Intervention: Office visit initial consultation
Number of subjects: 476
Study 34170884 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane blocks (n=29)
Number of subjects: 90
Study 34170884 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral blocks (n=30)
Number of subjects: 90
Study 34170884 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia alone (n=30)
Number of subjects: 90
Study 32129161 — intervention group
Group type: EXPERIMENTAL
Intervention: Darunavir-ritonavir (DRV/r) plus rilpivirine (RPV) once daily (QD)
Number of subjects: 41
Study 32129161 — intervention group
Group type: COMPARATOR
Intervention: Ongoing triple therapy
Number of subjects: 41
Study 33832537 — intervention group
Group type: EXPERIMENTAL
Intervention: FASTER (Freiburger Asperger‐Spezifische Therapie für ERwachsene)
Number of subjects: 360
Study 33832537 — intervention group
Group type: EXPERIMENTAL
Intervention: SCOTT&EVA (Social Cognition Training Tool)
Number of subjects: 360
Study 33832537 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 360
Study 32328036 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized group (γ IU/kg)
Number of subjects: 140
Study 32328036 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (0.15 IU/kg)
Number of subjects: 140
Study 32328036 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized group (0.23 IU/kg)
Number of subjects: 140
Study 34034262 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose loading
Number of subjects: 20
Study 34907523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multiple-injection costotransverse block (MICB) with three injections of 10 ml of ropivacaine (5 mg/ml)
Number of subjects: 36
Study 34907523 — intervention group
Group type: COMPARATOR
Intervention: Placebo with three injections of 10 ml of saline (0.9%)
Number of subjects: 36
Study 34907523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multiple-injection costotransverse block (MICB)
Number of subjects: 36
Study 33487505 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported coffee intake (more than 6 cups/day)
Number of subjects: 362571
Study 33487505 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically instrumented coffee intake (one cup higher)
Number of subjects: 362571
Study 32957332 — intervention group
Group type: EXPERIMENTAL
Intervention: Shexiang Tongxin dropping pill (STDP)
Number of subjects: 64
Study 32957332 — intervention group
Group type: COMPARATOR
Intervention: Control group (no STDP)
Number of subjects: 64
Study 33393630 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g fish oil/day (1.1 g eicosapentaenoic acid (EPA) + 0.8 g DHA)
Number of subjects: 2
Study 33393630 — intervention group
Group type: COMPARATOR
Intervention: 3 g corn oil/day (placebo)
Number of subjects: 2
Study 32850414 — intervention group
Group type: COMPARATOR
Intervention: IMRT alone (RT group)
Number of subjects: 84
Study 32850414 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT combined with concurrent cisplatin (CCRT group)
Number of subjects: 84
Study 35799195 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser surgery (group A)
Number of subjects: 63
Study 35799195 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrosurgery (group B)
Number of subjects: 63
Study 35799195 — intervention group
Group type: COMPARATOR
Intervention: Routine surgery (group C)
Number of subjects: 63
Study 35799195 — intervention group
Group type: COMPARATOR
Intervention: Laser surgery (group A), Electrosurgery (group B), Routine surgery (group C)
Number of subjects: 63
Study 33971912 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-aided somatosensory training
Number of subjects: 12
Study 33971912 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-stroke adults)
Number of subjects: 12
Study 32652092 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 10% spray
Number of subjects: 134
Study 32652092 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline 0.9%) spray
Number of subjects: 134
Study 35778281 — intervention group
Group type: EXPERIMENTAL
Intervention: PVRV‐NG
Number of subjects: 0
Study 35778281 — intervention group
Group type: COMPARATOR
Intervention: HDCV
Number of subjects: 0
Study 35778281 — intervention group
Group type: EXPERIMENTAL
Intervention: PVRV‐NG and HDCV (booster group)
Number of subjects: 0
Study 35778281 — intervention group
Group type: EXPERIMENTAL
Intervention: PVRV‐NG and HDCV
Number of subjects: 0
Study 34826225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritlecitinib (oral JAK3-selective inhibitor)
Number of subjects: 0
Study 34826225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33405253 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified uvulopalatopharyngoplasty (UPPP)
Number of subjects: 65
Study 32340927 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (20 mg)
Number of subjects: 36
Study 32340927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32024676 — intervention group
Group type: EXPERIMENTAL
Intervention: iPACK1
Number of subjects: 105
Study 32024676 — intervention group
Group type: EXPERIMENTAL
Intervention: iPACK2
Number of subjects: 105
Study 32024676 — intervention group
Group type: COMPARATOR
Intervention: TNB
Number of subjects: 105
Study 33965757 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear pedagogy (NLP)
Number of subjects: 66
Study 33965757 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential learning (DL)
Number of subjects: 66
Study 33965757 — intervention group
Group type: COMPARATOR
Intervention: Linear pedagogy (LP)
Number of subjects: 66
Study 32721994 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 75
Study 32721994 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postprandial levels of insulin, leptin, glucose, and ghrelin
Number of subjects: 75
Study 35488024 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazil nut group (n = 29)
Number of subjects: 55
Study 35488024 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 26)
Number of subjects: 55
Study 32928601 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental intervention for youths with T1D and their parents
Number of subjects: 0
Study 32663379 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg
Number of subjects: 273
Study 32663379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study 35297715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Walking (IW) - alternating 30 s treadmill walking and 30 s seated rests
Number of subjects: 18
Study 35297715 — intervention group
Group type: COMPARATOR
Intervention: Continuous Walking (CW) - treadmill walking without breaks
Number of subjects: 18
Study 35297715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Walking (IW)
Number of subjects: 18
Study 33206192 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol, 2000 IU/d)
Number of subjects: 25871
Study 33206192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25871
Study 35899436 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg b.i.d.)
Number of subjects: 12
Study 35899436 — intervention group
Group type: COMPARATOR
Intervention: Placebo (b.i.d.)
Number of subjects: 12
Study 33407413 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive arts-based intervention
Number of subjects: 154
Study 33407413 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual waitlist control
Number of subjects: 154
Study 33342331 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (individually modified education on diet, physical activity, and weight control)
Number of subjects: 281
Study 33342331 — intervention group
Group type: COMPARATOR
Intervention: Usual prenatal care (Control group)
Number of subjects: 281
Study 35073354 — intervention group
Group type: EXPERIMENTAL
Intervention: Low burden of cerebral hypoxia (n=86)
Number of subjects: 166
Study 35073354 — intervention group
Group type: EXPERIMENTAL
Intervention: High burden of cerebral hypoxia (n=28)
Number of subjects: 166
Study 33404656 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (40 mg/day)
Number of subjects: 140
Study 33404656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 36307360 — intervention group
Group type: EXPERIMENTAL
Intervention: STELAR intervention (multifaceted quality improvement program including educational outreach workshops, feedback of registry data, interprofessional education, barrier assessment, and action plan documentation)
Number of subjects: 3147
Study 36307360 — intervention group
Group type: EXPERIMENTAL
Intervention: STELAR intervention
Number of subjects: 3147
Study 36307360 — intervention group
Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 3147
Study 34233229 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (running at moderate intensity for 30 min per day, 5 days a week for 12 weeks)
Number of subjects: 224
Study 34233229 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (control group)
Number of subjects: 224
Study 34213870 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone/oxygen injection (25 mu-g/mL in 20 mL)
Number of subjects: 50
Study 34213870 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone acetate (40mg) and lidocaine (40mg in 20 mL)
Number of subjects: 50
Study 32086352 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35986684 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoluminal stenting followed by elective surgery 1‐4 weeks later
Number of subjects: 245
Study 33486426 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive visual stimuli (happy emojis)
Number of subjects: 0
Study 33486426 — intervention group
Group type: COMPARATOR
Intervention: Negative visual stimuli
Number of subjects: 0
Study 35428276 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting NV-HAP
Number of subjects: 15420
Study 32114572 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary retinol measurement using enzyme-linked immunosorbent assay
Number of subjects: 30
Study 32114572 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma retinol measurement using high-performance liquid chromatography
Number of subjects: 30
Study 33151474 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprasegmental phonological training (12-week training on stress, intonation, and rhythm in English)
Number of subjects: 160
Study 33151474 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprasegmental phonological training
Number of subjects: 160
Study 32109160 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose SVF
Number of subjects: 39
Study 32109160 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose SVF
Number of subjects: 39
Study 32109160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 36078566 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (TR)
Number of subjects: 44
Study 36078566 — intervention group
Group type: COMPARATOR
Intervention: Resistance Training with Pilates breathing (TR + P)
Number of subjects: 44
Study 33691706 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor residual spraying (IRS) with pirimiphos-methyl (Actellic®300 CS)
Number of subjects: 20000
Study 33691706 — intervention group
Group type: COMPARATOR
Intervention: ITNs alone
Number of subjects: 20000
Study 33156110 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D models
Number of subjects: 116
Study 33156110 — intervention group
Group type: COMPARATOR
Intervention: 2D images
Number of subjects: 116
Study 85096255 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAM)
Number of subjects: 0
Study 34845913 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-species mite allergen immunotherapy
Number of subjects: 125
Study 34845913 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-species mite allergen immunotherapy
Number of subjects: 125
Study 34845913 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 125
Study 34480096 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 230
Study 34480096 — intervention group
Group type: COMPARATOR
Intervention: Anthracycline-containing regimens
Number of subjects: 230
Study 34480096 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment (anthracycline or taxane)
Number of subjects: 230
Study 32270631 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) combined with conventional western medicine
Number of subjects: 49
Study 32270631 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine alone
Number of subjects: 49
Study 35585937 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET) plus Neurac method
Number of subjects: 100
Study 35585937 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 100